Email updates

Keep up to date with the latest news and content from Genome Biology and BioMed Central.

Research news

Embryonic vs somatic mutation

Jonathan B Weitzman

Author Affiliations

Genome Biology 2002, 3:spotlight-20020315-01  doi:10.1186/gb-spotlight-20020315-01


The electronic version of this article is the complete one and can be found online at:


Published:15 March 2002

© 2002 BioMed Central Ltd

Research news

Discussion of the potential of using pluripotent stem cells for tissue transplantation has raised issues about the frequency and types of spontaneous mutation in these cells. In the March 19 Proceedings of the National Academy of Sciences, Rachel Cervantes and colleagues from the University of Cincinnati, Ohio, report a study of spontaneous and induced mutagenic events in murine embryonic stem (ES) cells (Proc Natl Acad Sci USA 2002, 99:3586-3590). They used a mouse model with a disrupted marker gene encoding adenine phosphoribosyltransferase (APRT), allowing analysis of uniparental disomy or loss of heterozygosity. They found that the spontaneous mutation frequencies were significantly lower (100-fold less) in ES cells than in somatic fibroblast cells. While many spontaneous mutations lead to loss of heterozygosity (LOH) in both cell types, the mechanisms differed. LOH in fibroblasts was the result of mitotic recombination, while the ES cells had predominantly chromosomal loss and subsequent uniparental disomy. These observations raise concerns about the use in transplantation therapy of ES cells that have been extensively cultured ex vivo

References

  1. [http://www.pnas.org] webcite

    Proceedings of the National Academy of Sciences

  2. [http://www.uc.edu] webcite

    University of Cincinnati

  3. Adenine phosphoribosyltransferase-deficient mice develop 2,8-dihydroxyadenine nephrolithiasis.

    PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL